Combutec-2 (Sponge) Instructions for Use
ATC Code
D08AF (Nitrofuran derivatives)
Clinical-Pharmacological Group
A drug improving trophism and tissue regeneration, with antimicrobial activity for external use
Pharmacotherapeutic Group
Dermatoprotective agent
Pharmacological Action
Dermatoprotective agent. It is used to protect wound and burn surfaces, exerts an antiseptic effect, and promotes the development of granulations.
Indications
Second and third-degree A burns (covering surfaces cleansed of necrotic tissues); third-degree B burns (after eschar removal); flat granulating post-traumatic wounds; trophic ulcers; bedsores; autodermoplasty (wound preparation); covering donor sites after autodermoplasty.
ICD codes
| ICD-10 code | Indication |
| L89 | Decubitus ulcer and pressure area |
| L98.4 | Chronic skin ulcer, not elsewhere classified |
| T14.1 | Open wound of unspecified body region |
| T30 | Burns and corrosions of unspecified body region |
| Z51.4 | Preparatory procedures for subsequent treatment or examination, not elsewhere classified |
| ICD-11 code | Indication |
| EA40 | Tropical phagedenic ulcer |
| EF60 | Ischemic ulceration of the skin |
| EH90.Z | Pressure ulcer of unspecified degree |
| EM0Z | Unspecified skin disorder |
| ME60.2 | Ulcerative skin lesion of unspecified nature |
| ND56.1 | Open wound of unspecified body region |
| NE11 | Burn of unspecified body region |
| QB9A | Preparatory procedures for subsequent treatment |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Sponge
The plate is applied to the wound (including after harvesting a skin graft) with the porous surface, and its edges should overlap the wound edges by 0.5-1 cm.
The plate is fixed with 1-2 layers of gauze (without cotton wool).
The condition of the wound surface is monitored daily, once a day with scant exudate, twice a day with copious exudate.
Autodermoplasty is performed on areas where succulent pink granulations form under the plate.
Leave on the donor site until self-detachment upon complete epithelialization of the wound.
For post-traumatic wounds, it is recommended to use after cleansing the wound of necrotic tissues, with the beginning growth of healthy granulations, and during the epithelialization of small wounds.
For trophic ulcers and bedsores, it is recommended to use after cleansing the wound surface of necrotic tissues and achieving low bacterial contamination.
Adverse Reactions
Secondary infection; allergic reactions.
Contraindications
Hypersensitivity; copious wound exudation; skin necrosis; infected wounds (more than 100 thousand microbial bodies per 1 g of tissue).
Storage Conditions
Store at 15°C (59°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Sponge 50x50 mm: container 1 pc.
Marketing Authorization Holder
Belkozin – Luzhsky Plant, JSC (Russia)
Dosage Form
| Combutec-2 | Sponge 50×50 mm: container 1 pc. |
Dosage Form, Packaging, and Composition
Sponge 50×50 mm.
| 1 g | |
| Glutaral | 12 mg |
| Oxyquinoline sulfate (quinosol) | 200 mcg |
| Collagen (in the form of a 2% solution substance) | 972.8 mg |
| Boric acid | 15 mg |
1 pc. – containers (1) – cardboard packs.
Sponge 70x60 mm: container 1 pc.
Marketing Authorization Holder
Belkozin – Luzhsky Plant, JSC (Russia)
Dosage Form
| Combutec-2 | Sponge 70×60 mm: container 1 pc. |
Dosage Form, Packaging, and Composition
Sponge 70×60 mm.
| 1 g | |
| Glutaral | 12 mg |
| Oxyquinoline sulfate (quinosol) | 200 mcg |
| Collagen (in the form of a 2% solution substance) | 972.8 mg |
| Boric acid | 15 mg |
1 pc. – containers (1) – cardboard packs.
Sponge 90x90 mm: container 1 pc.
Marketing Authorization Holder
Belkozin – Luzhsky Plant, JSC (Russia)
Dosage Form
| Combutec-2 | Sponge 90×90 mm: container 1 pc. |
Dosage Form, Packaging, and Composition
Sponge 90×90 mm.
| 1 g | |
| Glutaral | 12 mg |
| Oxyquinoline sulfate (quinosol) | 200 mcg |
| Collagen (in the form of a 2% solution substance) | 972.8 mg |
| Boric acid | 15 mg |
1 pc. – containers (1) – cardboard packs.
Sponge 140x120 mm: container 1 pc.
Marketing Authorization Holder
Belkozin – Luzhsky Plant, JSC (Russia)
Dosage Form
| Combutec-2 | Sponge 140×120 mm: container 1 pc. |
Dosage Form, Packaging, and Composition
Sponge 140×120 mm.
| 1 g | |
| Glutaral | 12 mg |
| Oxyquinoline sulfate (quinosol) | 200 mcg |
| Collagen (in the form of a 2% solution substance) | 972.8 mg |
| Boric acid | 15 mg |
1 pc. – containers (1) – cardboard packs.
Sponge 240x140 mm: container 1 pc.
Marketing Authorization Holder
Belkozin – Luzhsky Plant, JSC (Russia)
Dosage Form
| Combutec-2 | Sponge 240×140 mm: container 1 pc. |
Dosage Form, Packaging, and Composition
Sponge 240×140 mm.
| 1 g | |
| Glutaral | 12 mg |
| Oxyquinoline sulfate (quinosol) | 200 mcg |
| Collagen (in the form of a 2% solution substance) | 972.8 mg |
| Boric acid | 15 mg |
1 pc. – containers (1) – cardboard packs.
Mildronate capsules 500mg, 90pcs
Belosalic, ointment, 30g
Cortexin, 10mg, 5ml, 10pcs
Fenotropil pills 100mg, 60pcs
Ingavirin capsules 90mg, 10pcs
No-spa pills 40mg, 64pcs
Phenibut-Vertex pills 250mg, 20pcs
Nootropil pills 800mg, 30pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Kagocel pills 12mg, 30pcs
Daivobet, ointment, 30g
Noopept, pills 10mg, 50pcs
Arbidol, capsules 100mg, 40pcs 